Sugi Predict

Sugi Predict / Compounds / SCHEMBL18257751

SCHEMBL18257751

SCHEMBL18257751

C=C(NCc1ccc(OC(=O)C2(C)COC(=O)OC2)cc1)NC(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.36
▸ CA1 P00915 2/20 0.36
▸ CA2 P00918 2/20 0.36
▸ HDAC1 Q13547 2/20 0.35
▸ NAMPT P43490 2/20 0.35
▸ FPR3 P25089 1/20 0.34
▸ FPR2 P25090 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ F2 P00734 1/20 0.34
▸ HTT P42858 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ MAPT P10636 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18257739 0.87 CA1 (0.39) GAACA1CA2HDAC1NAMPT
SCHEMBL18256760 0.87 CA1 (0.39) GAACA1CA2HDAC1NAMPT
SCHEMBL18257757 0.86 LIPE (0.36) GAACA1NAMPTFPR3FPR2
SCHEMBL20848344 0.75 POLB (0.40) GAAL3MBTL1HTTRAB9AALDH1A1
SCHEMBL19508729 0.74 LIPE (0.34) CA1NPC1RAB9AALDH1A1LMNA
SCHEMBL18256739 0.74 LIPE (0.34) CA1NPC1RAB9AALDH1A1LMNA
SCHEMBL16378767 0.72 AAK1 (0.50) GAACA1CA2NAMPTF2
SCHEMBL20848640 0.72 MAPT (0.38) GAAL3MBTL1HTTNPC1RAB9A
SCHEMBL16378747 0.72 GAA (0.50) GAACA1CA2NAMPTFPR3
SCHEMBL20848342 0.71 POLB (0.38) GAAL3MBTL1HTTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690380-B2 Antimicrobial guanidinium and thiouronium functionalized polymers CORAL BAY II, LLC (US) 2023-07-04 — — US disclosed
US-9854806-B2 Antimicrobial guanidinium and thiouronium functionalized polymers INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2018-01-02 — — US disclosed
US-20170303541-A1 ANTIMICROBIAL GUANIDINIUM AND THIOURONIUM FUNCTIONALIZED POLYMERS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-10-26 — — US disclosed
US-20160338356-A1 ANTIMICROBIAL GUANIDINIUM AND THIOURONIUM FUNCTIONALIZED POLYMERS INTERNATIONAL BUSINESS MACHINES CORPORATION 2016-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160338356-A1 ANTIMICROBIAL GUANIDINIUM AND THIOURONIUM FUNCTIONALIZED POLYMERS PUF60, CAPG, GMPS GAA 966/4885CA1 3435/4885CA2 2209/4885
US-20170303541-A1 ANTIMICROBIAL GUANIDINIUM AND THIOURONIUM FUNCTIONALIZED POLYMERS PUF60, CAPG, GMPS GAA 966/4885CA1 3435/4885CA2 2209/4885
US-11690380-B2 Antimicrobial guanidinium and thiouronium functionalized polymers PUF60, CAPG, GMPS GAA 966/4885CA1 3435/4885CA2 2209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.